Pediatric Cancers Clinical Trial
Official title:
Psychosocial Predictors of Child Adjustment and School Reintegration Outcome in a Pediatric Cancer Population
Verified date | July 2012 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
Primary Objectives:
1. To examine illness-related factors (i.e., severity of illness, quality of life rating)
as predictors or correlates of child adjustment to pediatric cancer.
2. To examine illness-related factors (i.e., severity of illness, quality of life rating)
as predictors of school reintegration (i.e., school attendance) in children with
pediatric cancer.
3. To examine a within-parent factor (i.e., parental stress) as a predictor or correlate
of child adjustment to pediatric cancer.
4. To examine a within-parent factor (i.e., parental stress) as a predictor or correlate
of school reintegration (i.e., school attendance).
Secondary Objectives:
1. To examine a second within-parent factor (i.e., parental perception of child
vulnerability) as a predictor or correlate of child adjustment to pediatric cancer.
2. To examine a second within-parent factor (i.e., parental perception of child
vulnerability) as a predictor or correlate of school reintegration (i.e., school
attendance) in children with pediatric cancer.
3. To develop a statistical model by which relative contributions of each predictor
variable (i.e., severity of illness, quality of life, parental stress, parental
perception of child vulnerability), as well as their interrelatedness, can be
understood in relation to child adjustment. Exploration of each variable's contribution
will affect the schematic organization of the model.
4. To examine demographic variables as covariates in the primary analyses. The variables
include: child's age, gender, grade, ethnicity, diagnosis, time since diagnosis, type
and duration of treatment, and time since school reintegration.
Status | Completed |
Enrollment | 91 |
Est. completion date | October 2010 |
Est. primary completion date | October 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Years to 17 Years |
Eligibility |
Inclusion Criteria: 1. Children between 6 and 17 years diagnosed with, and treated for, any type of cancer 2. Children enrolled in grades K through 12 3. Children who have actively participated in community or private school during the 2006-2007 academic year 4. Children who have experienced a period of absence from community or private school of at least two consecutive months as a result of medical treatment prior to school reintegration 5. Children who have fully reintegrated as a full-time student within the past 1-3 years 6. Parents and children who are either English- or Spanish-speaking and are able to read in either or both languages 7. Medical staff (i.e., physicians, nurse practitioners) involved in the children's medical decision-making Exclusion Criteria: 1. Children and/or parents diagnosed and/or identified as having mental retardation (IQ < 70) with concomitant adaptive behavior deficits or classified as having any type of Pervasive Developmental Disorder (PDD) 2. Children and/or parents who speak a language other than English or Spanish 3. Participant (e.g., parent or child) unwillingness to participate in any capacity |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | UT MD Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Severity of Illness [using The Severity of Illness Scale (SOIS)] | Completion of scale by medical staff, approximately 2-5 minutes | No | |
Primary | Quality of Life [using The Pediatric Quality of Life (PedsQL)] | Questionnaire, approximately 45 minutes to one hour for parent or non-parent caregivers to complete their measures | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00575926 -
Lingzhi for Cancer Children
|
Phase 3 | |
Completed |
NCT00588289 -
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
|
N/A | |
Completed |
NCT01875601 -
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00883688 -
Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
|
Phase 2 | |
Completed |
NCT02664389 -
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
|
N/A | |
Enrolling by invitation |
NCT02315599 -
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
|
||
Terminated |
NCT00591539 -
Carotid Artery Disease in Childhood Cancer Survivors
|
N/A | |
Completed |
NCT00675467 -
Palliative Care and Symptom Management for the Pediatric Oncology Patient
|
N/A | |
Recruiting |
NCT00698113 -
Parent-Delivered Massage in Paediatric Cancer
|
N/A |